Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Seminars in Nuclear Medicine|February 2, 2010
131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumorsFrank Grünwald, Samer Ezziddin
Seminars in Nuclear Medicine|February 2, 2010
Radioembolization of liver tumors with yttrium-90 microspheresHojjat Ahmadzadehfar, Hans-Jürgen Biersack, Samer Ezziddin
Seminars in Nuclear Medicine|December 22, 2015
Advances in Peptide Receptor Radionuclide TherapyAmir Sabet, Hans-Jürgen Biersack, Samer Ezziddin
Diagnostics (Basel, Switzerland)|March 25, 2022
Systemic Mastocytosis Treatment with Midostaurin: [<sup>18</sup>F]FDG PET/CT as a Potential Monitoring Tool for Therapy OutcomeCaroline Burgard, Florian Rosar, Fadi Khreish, et al.
Clinical Nuclear Medicine|January 25, 2020
Remember the Pitfall: Intrapancreatic Accessory Spleen Mimicking Neuroendocrine NeoplasmFlorian Rosar, Martin Ries, Fadi Khreish, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Active Lumbar Spondylodiscitis on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT Mimicking Bone MetastasisFlorian Rosar, Caroline Burgard, Raffaele Gargiulo, et al.
Clinical Nuclear Medicine|May 10, 2011
Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancerKhaled Alkhawaldeh, Hans-J Biersack, Anna Henke, et al.
Clinical Nuclear Medicine|September 6, 2011
The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysisKhaled Alkhawaldeh, Stephanie Faltten, Hans-J Biersack, et al.
Pageof 16